Sort By:
Date
Title
Category:

How do we value drugs? Reforms for better decisions and use.

| HTA Advisory Board, Library News, Presentations and Infographics, Regulatory Affairs

What can be Done to Improve Confidence and Trust in the Safety of the System for Pharmaceutical Products?

|

Managers ignore PV at their peril

| Pharmacovigilance

Rosalind Cox comments on new EU Medical Device Legislation

|

Getting good medicines to patients and keeping them there

|

A structured approach to assessment of product suitability for switch to OTC status in the EU

| Regulatory Affairs

Medicines for older people and the need to get on track

| Library News

Biosimilars in the EU - what have we learned so far?

| Biologics, News, Regulatory Advisory Board, Regulatory Affairs, Services News

Making a success of new drug development

| Regulatory Affairs

Changing the culture of drug safety

| Pharmacovigilance

Impact of the Paediatric Regulation on existing medicinal products – a review

| Paediatrics, Regulatory Affairs

NDA Intelligence

Subscribe to the latest intelligence from the true thought leaders in the field and access it at any time.

Sign In

Create Account

By signing up you are agreeing to our terms of service